idiopathic pulmonary fibrosis
GPTKB entity
Properties (63)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
lung disease
|
| gptkbp:age |
between 50 and 70 years
|
| gptkbp:associated_with |
autoimmune diseases
gastroesophageal reflux disease |
| gptkbp:challenges |
similarity to other lung conditions
|
| gptkbp:clinicalTrials |
available for management
for new antifibrotic agents honeycombing on imaging ongoing studies for new treatments progressive fibrosis testing new drug combinations unknown cause |
| gptkbp:collaborations |
between institutions and organizations
|
| gptkbp:community_service |
support groups available
critical for awareness and funding educational materials available online increasingly used for follow-up care under investigation for diagnosis and prognosis |
| gptkbp:communityPrograms |
available for patients and families
|
| gptkbp:demographics |
approximately 3 million cases worldwide
|
| gptkbp:diseaseResistance |
high-resolution CT scan
variable, often poor lung_biopsy |
| gptkbp:endOfLife |
requires planning and support
|
| gptkbp:enrollment |
varies by region and population
|
| gptkbp:environmental_impact |
exposure to certain toxins
|
| gptkbp:events |
Pulmonary Fibrosis Awareness Month
|
| gptkbp:function |
used to assess severity
|
| gptkbp:funding |
increasing interest
|
| gptkbp:gender |
more common in men
|
| gptkbp:geneticDiversity |
family history
|
| gptkbp:healthcare |
important for management
requires a pulmonologist for management |
| https://www.w3.org/2000/01/rdf-schema#label |
idiopathic pulmonary fibrosis
|
| gptkbp:impact |
lungs
pulmonary rehabilitation oxygen therapy antifibrotic medications can be significant can lead to anxiety and depression |
| gptkbp:inheritsFrom |
typically occurs in older adults
|
| gptkbp:judgingCriteria |
based on clinical, radiological, and histopathological findings
|
| gptkbp:lifespan |
varies, often 3 to 5 years post-diagnosis
|
| gptkbp:nutritionalValue |
important for overall health
|
| gptkbp:provides |
gptkb:American_Lung_Association
gptkb:Pulmonary_Fibrosis_Foundation |
| gptkbp:providesOpportunitiesFor |
important for coping strategies
|
| gptkbp:relatedPatent |
gptkb:pulmonary_hypertension
respiratory failure |
| gptkbp:research |
aimed at improving quality of life
ongoing to find causes |
| gptkbp:research_focus |
developing new therapies
understanding pathogenesis |
| gptkbp:riskManagement |
age
smoking |
| gptkbp:safety_features |
other interstitial lung diseases
|
| gptkbp:sustainabilityPractices |
recommended for care
|
| gptkbp:symptoms |
palliative care
shortness of breath chronic cough can vary widely among patients |
| gptkbp:takesPlaceIn |
considered in advanced cases
|
| gptkbp:trainingExercises |
tailored to individual capacity
|